Cargando…

Clinical Usefulness of Transjugular Liver Biopsy in Patients With Hematological Diseases With Liver Dysfunction

Introduction Transjugular liver biopsy (TJLB) is indicated for patients in whom percutaneous liver biopsy is contraindicated, such as those with hematological diseases complicated by liver dysfunction. However, the clinical utility of TJLB in this group of patients has not been thoroughly investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Toru, Kodama, Erina, Kobayashi, Takamasa, Azumi, Motoi, Nozawa, Yujiro, Iwanaga, Akito, Sano, Tomoe, Honma, Terasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669626/
https://www.ncbi.nlm.nih.gov/pubmed/34917436
http://dx.doi.org/10.7759/cureus.19555
_version_ 1784614816856408064
author Ishikawa, Toru
Kodama, Erina
Kobayashi, Takamasa
Azumi, Motoi
Nozawa, Yujiro
Iwanaga, Akito
Sano, Tomoe
Honma, Terasu
author_facet Ishikawa, Toru
Kodama, Erina
Kobayashi, Takamasa
Azumi, Motoi
Nozawa, Yujiro
Iwanaga, Akito
Sano, Tomoe
Honma, Terasu
author_sort Ishikawa, Toru
collection PubMed
description Introduction Transjugular liver biopsy (TJLB) is indicated for patients in whom percutaneous liver biopsy is contraindicated, such as those with hematological diseases complicated by liver dysfunction. However, the clinical utility of TJLB in this group of patients has not been thoroughly investigated. The objective of this study is to evaluate the clinical efficacy of TJLB in patients with hematological diseases complicated by liver dysfunction. Methods We analyzed the data of patients who developed liver disorders during treatment for hematological diseases at our hospital and required tissue diagnosis via TJLB. The clinical features of patients were analyzed. Results Twenty-seven patients (mean age, 60.07 years; 12 men, 15 women) requiring tissue diagnoses via TJLB after developing liver disorders while undergoing treatment for hematological diseases were enrolled. One patient with autoimmune hemolytic anemia was diagnosed with drug-induced liver injury; two patients with amyloidosis had nonalcoholic steatohepatitis; one patient with acute promyelocytic leukemia had a drug-induced liver injury; one patient with chronic myelomonocytic leukemia had liver infiltration caused by an underlying disease; three patients with idiopathic thrombocytopenic purpura had autoimmune hepatitis; four patients with malignant lymphoma had liver infiltration by the underlying disease, and one patient with multiple myeloma had liver disorder caused by disseminated intravascular coagulation. Moreover, one patient had hepatitis B reactivation, another had hepatitis E, and six patients had a drug-induced liver injury. The treatment regimen was altered in cases of liver infiltration caused by the underlying disease, and the drug was changed for patients with drug-induced liver injury. Conclusion The etiology of liver disorders in patients with hematological diseases varies widely. Therefore, histological diagnosis using TJLB is useful to determine an appropriate therapeutic strategy for underlying hematological diseases.
format Online
Article
Text
id pubmed-8669626
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-86696262021-12-15 Clinical Usefulness of Transjugular Liver Biopsy in Patients With Hematological Diseases With Liver Dysfunction Ishikawa, Toru Kodama, Erina Kobayashi, Takamasa Azumi, Motoi Nozawa, Yujiro Iwanaga, Akito Sano, Tomoe Honma, Terasu Cureus Gastroenterology Introduction Transjugular liver biopsy (TJLB) is indicated for patients in whom percutaneous liver biopsy is contraindicated, such as those with hematological diseases complicated by liver dysfunction. However, the clinical utility of TJLB in this group of patients has not been thoroughly investigated. The objective of this study is to evaluate the clinical efficacy of TJLB in patients with hematological diseases complicated by liver dysfunction. Methods We analyzed the data of patients who developed liver disorders during treatment for hematological diseases at our hospital and required tissue diagnosis via TJLB. The clinical features of patients were analyzed. Results Twenty-seven patients (mean age, 60.07 years; 12 men, 15 women) requiring tissue diagnoses via TJLB after developing liver disorders while undergoing treatment for hematological diseases were enrolled. One patient with autoimmune hemolytic anemia was diagnosed with drug-induced liver injury; two patients with amyloidosis had nonalcoholic steatohepatitis; one patient with acute promyelocytic leukemia had a drug-induced liver injury; one patient with chronic myelomonocytic leukemia had liver infiltration caused by an underlying disease; three patients with idiopathic thrombocytopenic purpura had autoimmune hepatitis; four patients with malignant lymphoma had liver infiltration by the underlying disease, and one patient with multiple myeloma had liver disorder caused by disseminated intravascular coagulation. Moreover, one patient had hepatitis B reactivation, another had hepatitis E, and six patients had a drug-induced liver injury. The treatment regimen was altered in cases of liver infiltration caused by the underlying disease, and the drug was changed for patients with drug-induced liver injury. Conclusion The etiology of liver disorders in patients with hematological diseases varies widely. Therefore, histological diagnosis using TJLB is useful to determine an appropriate therapeutic strategy for underlying hematological diseases. Cureus 2021-11-14 /pmc/articles/PMC8669626/ /pubmed/34917436 http://dx.doi.org/10.7759/cureus.19555 Text en Copyright © 2021, Ishikawa et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Gastroenterology
Ishikawa, Toru
Kodama, Erina
Kobayashi, Takamasa
Azumi, Motoi
Nozawa, Yujiro
Iwanaga, Akito
Sano, Tomoe
Honma, Terasu
Clinical Usefulness of Transjugular Liver Biopsy in Patients With Hematological Diseases With Liver Dysfunction
title Clinical Usefulness of Transjugular Liver Biopsy in Patients With Hematological Diseases With Liver Dysfunction
title_full Clinical Usefulness of Transjugular Liver Biopsy in Patients With Hematological Diseases With Liver Dysfunction
title_fullStr Clinical Usefulness of Transjugular Liver Biopsy in Patients With Hematological Diseases With Liver Dysfunction
title_full_unstemmed Clinical Usefulness of Transjugular Liver Biopsy in Patients With Hematological Diseases With Liver Dysfunction
title_short Clinical Usefulness of Transjugular Liver Biopsy in Patients With Hematological Diseases With Liver Dysfunction
title_sort clinical usefulness of transjugular liver biopsy in patients with hematological diseases with liver dysfunction
topic Gastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669626/
https://www.ncbi.nlm.nih.gov/pubmed/34917436
http://dx.doi.org/10.7759/cureus.19555
work_keys_str_mv AT ishikawatoru clinicalusefulnessoftransjugularliverbiopsyinpatientswithhematologicaldiseaseswithliverdysfunction
AT kodamaerina clinicalusefulnessoftransjugularliverbiopsyinpatientswithhematologicaldiseaseswithliverdysfunction
AT kobayashitakamasa clinicalusefulnessoftransjugularliverbiopsyinpatientswithhematologicaldiseaseswithliverdysfunction
AT azumimotoi clinicalusefulnessoftransjugularliverbiopsyinpatientswithhematologicaldiseaseswithliverdysfunction
AT nozawayujiro clinicalusefulnessoftransjugularliverbiopsyinpatientswithhematologicaldiseaseswithliverdysfunction
AT iwanagaakito clinicalusefulnessoftransjugularliverbiopsyinpatientswithhematologicaldiseaseswithliverdysfunction
AT sanotomoe clinicalusefulnessoftransjugularliverbiopsyinpatientswithhematologicaldiseaseswithliverdysfunction
AT honmaterasu clinicalusefulnessoftransjugularliverbiopsyinpatientswithhematologicaldiseaseswithliverdysfunction